Tag: South Africa

RIYADH, Saudi Arabia, Oct. 31, 2023 (GLOBE NEWSWIRE) — King Faisal Specialist Hospital and Research Centre (KFSH&RC) has achieved a significant milestone by successfully conducting liquid biopsies on patients spanning various age groups. This innovative approach offers a safer alternative to conventional tissue biopsies. Notably, KFSH&RC stands out as the first healthcare facility in the Middle East to adopt this cutting-edge technology.

This groundbreaking method is distinguished by its ability to detect approximately 50 genes associated with cancer and over 3,000 genetic mutations. This represents a pivotal advancement in patient care, eliminating the need to extract tissue from the affected area for examination. This transformative step greatly enhances healthcare outcomes and elevates the overall patient experience.

Liquid biopsy offers advantages over traditional tissue biopsies. It’s less invasive, involving a simple 10 ml blood sample that can be repeated during treatment. Additionally, it provides high accuracy in swiftly detecting tumor biomarkers, predicting treatment responses, identifying emerging mutations, and confirming the absence of tumor recurrence, marking a significant advancement in cancer science.

This technology presents a safer alternative to traditional biopsies for patients facing challenges in accessing affected tissue without surgical intervention, as seen in cases like lung cancer. It is particularly beneficial for elderly patients, for whom a lung tissue biopsy may not be suitable due to the potential for severe complications associated with it.

King Faisal Specialist Hospital and Research Centre Utilizes Early Cancer Detection Technology for 50 Genes_02King Faisal Specialist Hospital and Research Centre Utilizes Early Cancer Detection Technology for 50 Genes_02

As a strategic health partner at the Global Health Exhibition in Riyadh from October 29 to 31, KFSH&RC will showcase its pavilion in the accompanying exhibition, where visitors can explore Liquid biopsy technology and various other healthcare solutions and technologies.

Liquid biopsy technology holds promise for other stages of cancer treatment at KFSH&RC. Through the routine use of the test, it is possible to build a database of tumor-causing mutations in the local community, which helps in early diagnosis of cancer before tumors form, in addition to tracking changes in the patient’s condition, frequently during treatment, allowing timely adjustments to treatment plans and preventing worsening of the condition.

This achievement is a part of KFSH&RC’s ongoing commitment to harness advanced technologies for enhancing operational excellence and patient care. The test facilitates swift clinical decision-making for cancer patient management and reduces both the testing time and its process through full automation.

KFSH&RC stands as one of the world’s prominent institutions in delivering specialized healthcare, leading the way in innovation, and serving as an advanced hub for medical research and education. Furthermore, it actively endeavors to advance medical technologies and elevate global healthcare standards through collaborations with significant local, regional, and international organizations, aiming to deliver world-class clinical, research, and educational services.

Contact information:
kfshrc@mcsaatchi.com

Photos accompanying this announcement are available at:

https://www.globenewswire.com/NewsRoom/AttachmentNg/3ba7a2cd-ae09-4d9a-8658-a5efc2b198c3

https://www.globenewswire.com/NewsRoom/AttachmentNg/9de0dc61-7dc5-47e4-af70-09088ad689e1

GlobeNewswire Distribution ID 8969156

LONDON, Oct. 31, 2023 (GLOBE NEWSWIRE) — More than 400 delegates from over 35 countries are expected to attend the 17th annual Global Residence and Citizenship Conference, which takes place next week (8-10 November) at the Shangri-La Hotel DIFC in Dubai, UAE.

Hosted by world-leading international citizenship and residence advisory firm Henley & Partners, this annual event has become the world’s largest and most significant conference on private wealth and investment migration, bringing together presidents, prime ministers, senior government ministers and officials, leading academics, private client advisors, wealth management professionals, and top-tier financial and business media.

The 2023 conference program features sophisticated, cutting-edge content on the major developments shaping investment migration and geopolitics today, offering delegates the opportunity to engage with the world’s leading minds and latest ideas around the central themes of global citizenship and interconnectivity.

Dr. Christian H. Kalin, Group Chairman of Henley & Partners, who will also be speaking at the conference, points out that there could not be a more relevant and necessary time to connect across borders as citizens of the world. “At a moment in our history when our world seems increasingly fractured and polarized, it is more important than ever for us to focus our minds on our shared humanity and how we can be stronger together. While it may mean different things to different people, global citizenship is based on the principle that we all have responsibilities to the world as a whole, rather than just our own local communities or countries. This conference aims to expand our horizons through global learning and understanding so that we can effect change in a more meaningful sense on both a small and larger scale.”

Notable key speakers at the conference include the Prime Ministers of Montenegro, H.E. Dr. Dritan Abazovic, and of Grenada, the Hon. Dickon Mitchell, as well as the former President and Speaker of the Parliament of the Maldives, the Hon. Mohamed Nasheed. CEO of the Dubai Economic Development Corporation, Hadi Badri, along with Prof. Dr. Christian Joppke of the Institute of Sociology at the University of Bern in Switzerland, Dr. Titus Gebel, President of the Free Cities Foundation in Germany, Prof. Dr. Khalid Koser, Executive Director of the Global Community Engagement and Resilience Fund, Chief Partnership Officer of Women in AI, Middle East, Debbie Botha, and Dr. Parag Khanna, Founder and CEO of Climate Alpha in Singapore, among many others. They all will share their perspectives on the key social, economic, political and environmental trends shaping our world.

Another highlight of the conference will be the 2023 Global Citizen Award Dinner on 9 November to honor a remarkable individual working to advance one of the global challenges affecting humanity today. Hosted in collaboration with the Swiss non-profit humanitarian organization Andan Foundation, this year’s laureate will be announced at the gala event and the net proceeds of the evening will be donated to the foundation which focuses on self-reliance of refugees through education, entrepreneurship, and employment.

Notes to Editors

For further information and media accreditation to attend the 17th annual Global Residence and Citizenship Conference, please contact:

Sarah Nicklin
Group Head of Public Relations
sarah.nicklin@henleyglobal.com
Mobile: +27 72 464 8965

About Henley & Partners

Henley & Partners is the global leader in residence and citizenship by investment. Each year, hundreds of wealthy individuals and their advisors rely on our expertise and experience in this area. The firm’s highly qualified professionals work together as one team in over 40 offices worldwide.

The concept of residence and citizenship by investment was created by Henley & Partners in the 1990s. As globalization has expanded, residence and citizenship have become topics of significant interest among the increasing number of internationally mobile entrepreneurs and investors whom we proudly serve every day.

Henley & Partners also runs the world’s leading government advisory practice for investment migration, which has raised more than USD 12 billion in foreign direct investment. Trusted by governments, the firm has been involved in strategic consulting and in the design, set-up, and operation of the world’s most successful residence and citizenship programs.
https://www.henleyglobal.com

GlobeNewswire Distribution ID 1000896628

With a few clicks, developers can now sign up and integrate Pixalate’s advertising fraud prevention technology into their apps and websites without signing long-term contracts

London, UK, Oct. 30, 2023 (GLOBE NEWSWIRE) — Pixalate, the global market-leading ad fraud protection, privacy, and compliance analytics platform, today announced general availability of its self-service Ad Fraud Prevention API. With no annual commitments or upfront costs, developers and publishers of all sizes can access Pixalate’s reliable and low-latency solution to easily scale and grow.

Pixalate APIs are powered by the company’s MRC-accredited Analytics platform. Accreditation areas include sophisticated invalid traffic (SIVT) detection & filtration for both display and video across Connected TV (CTV), mobile app, mobile web, and desktop.

Access to MRC-accredited ad fraud prevention tools has historically been limited to large, enterprise sized publishers & developers. Pixalate’s self-service API gives smaller developers an upper hand to scale their platforms by protecting existing ad revenue streams and fortifying the integrity of their advertising inventory against bad actors.

Using most globally-accepted credit cards, customers can sign up in minutes, choose the plan that’s right for them, and immediately incorporate Pixalate’s ad fraud prevention insights into their apps. Subscriptions start at $99 a month and give developers the freedom to adjust based on usage. When a customer exceeds a plan’s usage quota, consumption-based pricing kicks in without any interruption to the service.

Key Benefits Include: 

• Reduce clawbacks. Protects publishers & developers’ revenue by taking steps to improve ad traffic quality.
• Align with major exchanges. Enable developers to use the same ad fraud technology as major exchanges.
• Combat ad fraud. Prevents 40+ types of invalid traffic (IVT) & fraud vectors that harm app traffic quality.
• Prevent getting blocklisted. Bake fraud prevention into apps from the ground up.
• Billing Dashboard. View real-time API usage and charges on the billing dashboard.
• Ease of Integration. With just a few clicks, any developer can sign up with a freemium plan and begin integrating the APIs with a few lines of code.

API Input Parameters:

• IP address: Analyzes an IP address (either IPv4 or IPv6) to check for any associated risks.
• Device Identifier: Examines the device identifier to detect any abnormalities or signs of fraudulent activity.
• User Agent: Evaluates the user agent data to identify potentially malicious software or bots.

API Output Parameters:

• Fraud Risk Assessment: Subscribers can request a risk score from Pixalate’s servers to gauge the likelihood of an IP, Device ID, or User Agent being compromised or engaged in malicious activity.

Platforms Supported

• Websites
• Mobile (iOS, Android)
• Connected TV (Roku, Fire TV, Samsung, LG, tvOS and more)

SDKs

• iOS
• Android

To learn more about the Ad Trust & Safety API suite, visit https://developer.pixalate.com.

About Pixalate
Pixalate is the market-leading fraud protection, privacy, and compliance analytics platform for Connected TV (CTV) and Mobile Advertising. We work 24/7 to guard your reputation and grow your media value. Pixalate offers the only system of coordinated solutions across display, app, video, and CTV for better detection and elimination of ad fraud. Pixalate is an MRC-accredited service for the detection and filtration of sophisticated invalid traffic (SIVT) across desktop and mobile web, mobile in-app, and CTV advertising.

Media Contact: press@pixalate.com

Disclaimer

As used herein, and per the Media Rating Council, Inc. (MRC), “‘Fraud’ is not intended to represent fraud as defined in various laws, statutes and ordinances or as conventionally used in U.S. Court or other legal proceedings, but rather a custom definition strictly for advertising measurement purposes;” and “‘Invalid Traffic’ is defined generally as traffic that does not meet certain ad serving quality or completeness criteria, or otherwise does not represent legitimate ad traffic that should be included in measurement counts. Among the reasons why ad traffic may be deemed invalid is it is a result of non-human traffic (spiders, bots, etc.), or activity designed to produce fraudulent traffic.”

Press
Pixalate Inc.
press@pixalate.com

GlobeNewswire Distribution ID 8968701